Investors alleged that drugmaker Pfizer violated federal securities laws by making false, misleading or incomplete statements regarding the cardiovascular risks of Celebrex and Bextra. Seeger Weiss helped secure a $486 million settlement on behalf of the investors.
Prior results do not guarantee or predict a similar outcome in any future matter.
Meta has agreed to settle claims brought by 29 State Attorneys General in the midst of a federal bellwether trial in the Social Media Adolescent Addiction/Personal Injury Products Liability multi-district litigation (MDL). Seeger Weiss Founding Partner Christopher A. Seeger serves as Counsel to the Co-Lead Counsel and Settlement Counsel in the MDL for the school […]
Seeger Weiss is proud to announce that fifteen of our attorneys have been recognized in the 2027 edition of The Best Lawyers in America, including in the Best Lawyers: Ones to Watch in America, and Lawyer of the Year lists. These attorneys have been celebrated for their work in mass tort and class actions, personal […]
Seeger Weiss has been named as Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards. This honor is reflects to the Seeger Weiss team’s efforts throughout the entire Pharmaceutical Litigation practice area, but specifically the firm’s work on the GLP-1 RA and Depo-Provera litigations. Partner Parvin Aminolroaya […]
The Plaintiffs’ Negotiation Committee in multi-district litigation 2738 (District of New Jersey), with the support and endorsement of the Plaintiffs’ Executive Committee and the Plaintiffs’ Steering Committee, announces today that it has reached a historic uncapped global settlement with J&J, Company to pay a minimum $5.8 billion settlement to resolve all current and pending talcum […]
Seeger Weiss attorneys played a key role in this case, helping negotiate an efficient and positive settlement for investor plaintiffs. Partner Dave Buchanan developed a slate of experts to overcome Pfizer’s early science challenges to the case. Founding partner Chris Seeger led the plaintiff’s presentation and examinations during the seven-day Daubert hearing.
Following pre-trial motion practice and ensuing appeals, Pfizer settled the case, resulting in a $486 million cash settlement fund for the class of aggrieved investors.
Pfizer allegedly misled shareholders about risks associated with two prescription medications: arthritis medication, Celebrex, and painkiller, Bextra. Evidence indicated that Pfizer recognized the potential cardiovascular risks of these medications but deliberately concealed these risks from shareholders. Plaintiffs alleged that these omissions violated federal securities laws, defrauding a class of investors.
Meta has agreed to settle claims brought by 29 State Attorneys General in the midst of a federal bellwether trial in the Social Media Adolescent Addiction/Personal Injury Products Liability multi-district litigation (MDL). Seeger Weiss Founding Partner Christopher A. Seeger serves as Counsel to the Co-Lead Counsel and Settlement Counsel in the MDL for the school […]
Seeger Weiss is proud to announce that fifteen of our attorneys have been recognized in the 2027 edition of The Best Lawyers in America, including in the Best Lawyers: Ones to Watch in America, and Lawyer of the Year lists. These attorneys have been celebrated for their work in mass tort and class actions, personal […]
Seeger Weiss has been named as Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards. This honor is reflects to the Seeger Weiss team’s efforts throughout the entire Pharmaceutical Litigation practice area, but specifically the firm’s work on the GLP-1 RA and Depo-Provera litigations. Partner Parvin Aminolroaya […]
The Plaintiffs’ Negotiation Committee in multi-district litigation 2738 (District of New Jersey), with the support and endorsement of the Plaintiffs’ Executive Committee and the Plaintiffs’ Steering Committee, announces today that it has reached a historic uncapped global settlement with J&J, Company to pay a minimum $5.8 billion settlement to resolve all current and pending talcum […]